Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OmniAb (OABI) Research & Development (2022 - 2025)

OmniAb (OABI) has disclosed Research & Development for 4 consecutive years, with $13.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development rose 4.53% to $13.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $47.8 million, a 13.35% decrease, with the full-year FY2025 number at $47.8 million, down 13.35% from a year prior.
  • Research & Development was $13.9 million for Q4 2025 at OmniAb, up from $10.4 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $14.8 million in Q4 2023 to a low of $10.4 million in Q3 2025.
  • A 4-year average of $13.0 million and a median of $13.3 million in 2024 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: increased 27.73% in 2023, then dropped 22.07% in 2025.
  • OmniAb's Research & Development stood at $12.9 million in 2022, then grew by 14.3% to $14.8 million in 2023, then fell by 9.89% to $13.3 million in 2024, then rose by 4.53% to $13.9 million in 2025.
  • Per Business Quant, the three most recent readings for OABI's Research & Development are $13.9 million (Q4 2025), $10.4 million (Q3 2025), and $10.9 million (Q2 2025).